A new report by the Centers for Disease Control and Prevention (CDC) recently delivered more bad news regarding the nation’s devastating opioid epidemic: overdoses from opioids jumped approximately 30 percent from the third quarter 2016 through third quarter 2017. Though the number of people suffering from opioid use disorder appears to be relatively stable, the spike in overdoses appears to be the result of more dangerous opioids, such as the highly potent opioid fentanyl, which have been flooding the country in recent years.Read More
CleanSlate is proud to welcome the Indiana communities in Indianapolis and Bloomington to our open houses and ribbon cuttings in April. Speakers at these events include Patrick J. Kennedy, Former U.S. Representative/ CleanSlate Board member; Jim McClelland, Executive Director for Drug Prevention, Treatment and Enforcement for the State of Indiana; Justin Phillips, Founder and Executive Director of Overdose Lifeline; Dr. Joan Duwve, Chief Medical Officer of Indiana State Department of Health and Associate Dean at The Fairbanks School of Public Health at Indiana University–Purdue University Indianapolis; and Darrell Mitchell, Executive Director at Progress House.Read More
An estimated 175 people die every day in the United States from drug overdoses, including overdoses from prescription opioid painkillers and heroin. We are witnessing an unrelenting crisis in our country. Getting proven treatment to those suffering from addiction is one of the biggest challenges in battling the opioid epidemic.Read More
When Indiana’s Governor, Eric Holcomb, took office in January of 2017, one of his top priorities was battling the state’s opioid epidemic. In fact, given that Indiana deaths caused by opioids have risen 271% from 2010 to 2016, this was one of five pillars of Holcomb’s governing agenda. In pursuit of this mission, the Governor’s first step was appointing Jim McClelland as the inaugural Executive Director for Drug Prevention, Treatment, and Enforcement for the State of Indiana. This new cabinet position reports directly to the Governor and coordinates, aligns, and focuses the efforts of nine state agencies in response to the opioid epidemic. McClelland also chairs the Indiana Commission to Combat Drug Abuse.Read More
Two senior executives of CleanSlate, a national leader in outpatient addiction medicine, will speak at the 2018 National Rx Drug Abuse & Heroin Summit, the largest national collaboration of federal, state and local professionals seeking to address prescription drug and opioid abuse, misuse and diversion. CleanSlate is also a Gold Level Sponsor.
The Rx Summit runs from April 2nd through April 5th at the Hyatt Regency Atlanta.Read More
National Medical Group Opens Fifth Location in Florida to Fight Addiction EpidemicJacksonville, Fl. – CleanSlate announced today the opening of its fifth outpatient addiction treatment medical facility in Florida to combat the deadly opioid addiction epidemic and save lives. The new center is located at 1128 N. Laura St. in Jacksonville and opened its doors to patients on March 5th.
“No state has been unscathed by this deadly epidemic, but Florida has been hit particularly hard,” said Adam McPhee, CleanSlate’s President of Operations, Eastern Division. “We’re looking forward to working closely with Jacksonville’s Mayor, Lenny Curry, and other community leaders to provide life-saving treatment to those who need it.”Read More
As the opioid epidemic devastates every corner of this country, there’s a reason that medication-assisted treatment (MAT) has been getting more and more attention by the media and policymakers:
But misunderstandings around MAT persist. This starts with the term MAT itself, based on the idea that medication is an assistance to other, primary forms of treatment for addiction, such as counseling. The Substance Abuse and Mental Health Services Administration recently clarified this view with a new recommendation stating that patients with opioid use disorder (OUD) should be given access to the three FDA-approved medications: methadone, buprenorphine or naltrexone. SAMHSA, which is part of the U.S. Health and Human Services Department, is clear on this point: “It is not sound medical practice to deny people with OUD access to FDA-approved medications for their illness.”Read More
This Wed., Feb. 21st, CleanSlate will proudly welcome a group of special guests along with members of the community at the grand opening event for our new center in South Philadelphia. Philadelphia Mayor James Kenney and other dignitaries will speak about the significance of CleanSlate's office-based opioid treatment program in a city that has been particularly devastated by the opioid crisis.Read More
The figures were Daniel Kelsey, 32, and Heather Kelsey, 30, both dead from an overdose of fentanyl, a drug 50 times more potent than heroin.Read More
Disaster emergencies used to be declared for extraordinary catastrophes like wildfires or terrorist attacks. Now they’re declared for out of control overdose deaths.Read More